Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,741.04
+1,609.91(+3.28%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

USANA Health Sciences, Inc. (USNA)

NYSE - Nasdaq Real-time price. Currency in USD

Add to watchlist

45.55

-1.55

(-3.29%)

At close: 04:00PM EDT

45.55

0.00

(0.00%)

After hours:

04:07PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	876.41M
Enterprise value	549.39M
Trailing P/E	14.19
Forward P/E	17.73
PEG ratio (5-yr expected)	1.48
Price/sales (ttm)	0.98
Price/book (mrq)	1.75
Enterprise value/revenue	0.61
Enterprise value/EBITDA	5.42

Trading information

Stock price history

Beta (5Y monthly)	0.91
52-week change ³	-29.06%
S&P500 52-week change ³	22.38%
52-week high ³	69.60
52-week low ³	41.45
50-day moving average ³	46.68
200-day moving average ³	52.54

Share statistics

Avg vol (3-month) ³	87.51k
Avg vol (10-day) ³	86.4k
Shares outstanding ⁵	19.24M
Implied shares outstanding ⁶	19.24M
Float ⁸	10.04M
% held by insiders ¹	41.28%
% held by institutions ¹	55.90%
Shares short (15 Apr 2024) ⁴	260.23k
Short ratio (15 Apr 2024) ⁴	2.73
Short % of float (15 Apr 2024) ⁴	2.30%
Short % of shares outstanding (15 Apr 2024) ⁴	1.35%
Shares short (prior month 15 Mar 2024) ⁴	255.09k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	2:1
Last split date ³	23 Nov 2016

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2023
Most-recent quarter (mrq)	30 Mar 2024

Profitability

Profit margin	6.88%
Operating margin (ttm)	10.83%

Management effectiveness

Return on assets (ttm)	9.20%
Return on equity (ttm)	12.97%

Income statement

Revenue (ttm)	900.45M
Revenue per share (ttm)	46.84
Quarterly revenue growth (yoy)	-8.30%
Gross profit (ttm)	N/A
EBITDA	103.48M
Net income avi to common (ttm)	61.94M
Diluted EPS (ttm)	3.21
Quarterly earnings growth (yoy)	-10.00%

Balance sheet

Total cash (mrq)	328.34M
Total cash per share (mrq)	17.12
Total debt (mrq)	1.32M
Total debt/equity (mrq)	0.26%
Current ratio (mrq)	3.74
Book value per share (mrq)	26.08

Cash flow statement

Operating cash flow (ttm)	N/A
Levered free cash flow (ttm)	N/A